• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP BR (ASSAY FOR CA 27.29); CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE:

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP BR (ASSAY FOR CA 27.29); CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE: Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/09/2013
Event Type  malfunction  
Event Description
Falsely low advia centaur cp br (assay for ca 27.29) results were obtained by the customer on four patient samples and they were considered discordant when compared to higher test history results.The patients are undergoing chemotherapy and the lower br (assay for ca 27.29) results were questioned by the physician.There is no known report of adverse health consequences due to the discordant lower advia centaur cp br (assay for ca 27.29) results.
 
Manufacturer Narrative
The cause for the falsely low advia centaur cp br (assay for ca 27.29) results when compared to higher test history results is unknown.The customer's quality control results were within acceptable ranges and the customer did not observed any other discordant results for other advia centaur cp assays that were being run at the time.No conclusion can be drawn.The limitations section of the instructions for use states the following: "note do not interpret levels of ca 27.29 as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 27.29 within the range observed in healthy individuals.Additionally, elevated levels of ca 27.29 can be observed in patients with nonmalignant diseases.Measurements of ca 27.29 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP BR (ASSAY FOR CA 27.29)
Type of Device
CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE:
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stephen perry
333 coney street
east walpole, MA 02032
5086604163
MDR Report Key3549036
MDR Text Key4213666
Report Number1219913-2013-00322
Device Sequence Number1
Product Code MOI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K982680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Medical Technologist
Remedial Action Inspection
Type of Report Initial
Report Date 12/11/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Medical Technologist
Device Expiration Date04/13/2013
Device Model NumberN/A
Device Catalogue Number03896216
Device Lot Number047207
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/11/2013
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-